Close

Ultragenyx Pharma (RARE) Announces Positive, Interim Top-Line Data from KRN23 Phase 2 in XLH

Go back to Ultragenyx Pharma (RARE) Announces Positive, Interim Top-Line Data from KRN23 Phase 2 in XLH